Research


May 15, 2023

American Cancer Society Funds UAMS Study of ACA’s Impact on Breast Cancer Treatment

David Robinson

Chenghui Li, Ph.D., said findings from her study should provide important insights into how the Affordable Care Act has impacted racial disparities in breast cancer treatment.

LITTLE ROCK — An American Cancer Society grant will support a University of Arkansas for Medical Sciences (UAMS) study of the Affordable Care Act’s (ACA) influence on racial disparities in the use of a common, life-saving treatment for Arkansas breast cancer patients. The two-year, $222,000 grant is led by Chenghui Li, Ph.D., an associate professor…


May 2, 2023

UAMS Researchers Find Financial Burdens for Cancer Survivors Vary by Insurance Type

David Wise

Cancer Patient Looking Stressed

FAYETTEVILLE — Rural women cancer survivors are more likely to experience financial strain related to basic household needs rather than medical debt, according to researchers from the University of Arkansas for Medical Sciences (UAMS) Office of Community Health & Research. The study, “It was kind of a nightmare, it really was:” Financial Toxicity Among Rural…


May 1, 2023

UAMS, NIH Study Finds Consoling, Other Techniques Better Than Drug Therapies for Newborns with Opioid Withdrawal

David Robinson

UAMS’ Jessica Snowden, M.D., said the study’s findings provide the first strong evidence needed to help end hospitals’ widely varying treatments of Neonatal Opioid Withdrawal Syndrome.

LITTLE ROCK — A groundbreaking nationwide clinical trial in which the University of Arkansas for Medical Sciences (UAMS) played a key role has confirmed an effective way to wean newborns from opioid withdrawal symptoms that substantially reduces hospital stays and the traditional use of drug therapies. Using an “Eat, Sleep, Console” (ESC) care approach resulted…


March 30, 2023

UAMS Researcher Awarded $1.8 Million to Study Potential Treatments for Neurological Diseases

Linda Satter

UAMS research scientist Fang Zheng, Ph.D., recently received from The National Institutes of Health a $1.8 million grant to, to continue research that could lead to new treatments for epilepsy and other neurological diseases.

LITTLE ROCK — The National Institutes of Health (NIH) has awarded a $1.8 million grant to Fang Zheng, Ph.D., an associate professor of pharmacology and toxicology at the University of Arkansas for Medical Sciences (UAMS), to continue research that could lead to new treatments for epilepsy and other neurological diseases. The NIH’s National Institute of…


March 27, 2023

Student Research Day Continues to Grow with Inclusion of Northwest Campus

Andrew Vogler

Student Research Day

Graduate and professional students, postdoctoral researchers, medical staff and fellows presented their research at the University of Arkansas for Medical Sciences’ (UAMS) Student Research Day, a university-wide event hosted by the Division of Research and Innovation, Academic Affairs, the Graduate School, the Northwest Regional Campus and Academic Senate. This year’s event was the first in…


NIH, NSF Fund UAMS Study of Rapid Genomic Testing to Aid Treatment of Dangerous Antibiotic-Resistant Infections

David Robinson

Se-Ran Jun, Ph.D., hopes her research will lead to rapid, life-saving genomic information for doctors treating the most dangerous antibiotic-resistant infections.

LITTLE ROCK — Two national grants are helping researchers at the University of Arkansas for Medical Sciences (UAMS) toward their goal of providing rapid, life-saving genomic information to doctors treating the most dangerous antibiotic-resistant infections. The study began with a $50,000 pilot award from the UAMS Translational Research Institute, which was used to gather data…


March 13, 2023

UAMS’ Lawrence Cornett, Ph.D., Receives National Award for NIH IDeA Contributions

David Robinson

Larry Cornett, Ph.D. (center),received the W. Fred Taylor Ph.D. Award at a ceremony in Washington, D.C., here with Prakash Nagarkatti, Ph.D., (left), chair of the EPSCoR/IDeA Foundation, and Taylor.

LITTLE ROCK — The University of Arkansas for Medical Sciences’ (UAMS) Lawrence Cornett, Ph.D., has received the W. Fred Taylor Ph.D. Award in recognition of his significant contributions to the National Institutes of Health (NIH) Institutional Development Award (IDeA) program. The award presentation took place Feb. 28 at the Established Program to Stimulate Competitive Research…


February 27, 2023

UAMS Researchers Produce Journal’s Top Cited, Most Downloaded Article on COVID-19 Vaccine Hesitancy

David Robinson

Pearl McElfish, Ph.D., MBA

LITTLE ROCK — A University of Arkansas for Medical Sciences (UAMS) research team’s article on COVID-19 vaccine hesitancy has been recognized by the publisher of Clinical and Translational Science for having its top-cited article in 2022 and the most downloaded paper since its publication in 2021. The article, “COVID-19 Vaccine Hesitancy: Race/Ethnicity, Trust and Fear,”…


December 22, 2022

UAMS Garners Multiple Honors in 2022 while Fulfilling Missions

Ben Boulden

The year of 2022 was one of transition from COVID-19 pandemic restrictions and the Omicron surge in case numbers to, by the fall, in-person classes for students, public events and an easing of safety protocols.

Two years of battling the pandemic and its effects resulted in a 2022 that was the closest yet to a pre-COVID normal at UAMS. The university never faltered in its devotion to its missions. UAMS seized the opportunity the year brought to renew its focus on them in a way that earned it praise and…


December 19, 2022

U.S. Defense Department Awards UAMS Cancer Researcher $760,000 to Study Aggressive Type of Lymphoma

Marty Trieschmann

Samantha Kendrick, Ph.D., has received a $760,000 grant from the U.S. Department of Defense to study diffuse large B-cell lymphoma (DLBCL).

LITTLE ROCK — Samantha Kendrick, Ph.D., assistant professor in the Department of Biochemistry and Molecular Biology at the University of Arkansas for Medical Sciences (UAMS), has received a $760,000 grant from the U.S. Department of Defense to study a fast-growing type of non-Hodgkin lymphoma common among veterans and military personnel.



Previous page Next page